282 related articles for article (PubMed ID: 25884497)
1. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis.
Gabriel M; Delforge Y; Deward A; Habraken Y; Hennuy B; Piette J; Klinck R; Chabot B; Colige A; Lambert C
BMC Cancer; 2015 Apr; 15():227. PubMed ID: 25884497
[TBL] [Abstract][Full Text] [Related]
2. Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells.
Anufrieva KS; Shender VО; Arapidi GP; Pavlyukov MS; Shakhparonov MI; Shnaider PV; Butenko IO; Lagarkova MA; Govorun VM
Genome Med; 2018 Jun; 10(1):49. PubMed ID: 29950180
[TBL] [Abstract][Full Text] [Related]
3. Multiple effects of digoxin on subsets of cancer-associated genes through the alternative splicing pathway.
Lu GY; Liu ST; Huang SM; Chang YL; Lin WS
Biochimie; 2014 Nov; 106():131-9. PubMed ID: 25193633
[TBL] [Abstract][Full Text] [Related]
4. Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
Wang J; Pabla N; Wang CY; Wang W; Schoenlein PV; Dong Z
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1300-7. PubMed ID: 16849690
[TBL] [Abstract][Full Text] [Related]
5. Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells.
Katsarou ME; Thomadaki H; Katsaros N; Scorilas A
Biol Chem; 2007 Aug; 388(8):773-8. PubMed ID: 17655495
[TBL] [Abstract][Full Text] [Related]
6. Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS.
Hara H; Takeda T; Yamamoto N; Furuya K; Hirose K; Kamiya T; Adachi T
FEBS J; 2013 Jul; 280(14):3313-27. PubMed ID: 23648111
[TBL] [Abstract][Full Text] [Related]
7. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
[TBL] [Abstract][Full Text] [Related]
8. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
9. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing.
Araki S; Dairiki R; Nakayama Y; Murai A; Miyashita R; Iwatani M; Nomura T; Nakanishi O
PLoS One; 2015; 10(1):e0116929. PubMed ID: 25581376
[TBL] [Abstract][Full Text] [Related]
11. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
12. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
[TBL] [Abstract][Full Text] [Related]
13. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
Wang G; Dombkowski A; Chuang L; Xu XX
Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.
Ma W; Lin Y; Xuan W; Iversen PL; Smith LJ; Benchimol S
Oncogene; 2012 Feb; 31(8):1024-33. PubMed ID: 21765469
[TBL] [Abstract][Full Text] [Related]
15. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress.
Lemaitre F; Chakrama F; O'Grady T; Peulen O; Rademaker G; Deward A; Chabot B; Piette J; Colige A; Lambert C; Dequiedt F; Habraken Y
Nucleic Acids Res; 2022 Dec; 50(22):12768-12789. PubMed ID: 36477312
[TBL] [Abstract][Full Text] [Related]
17. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.
Liu H; Yin J; Wang C; Gu Y; Deng M; He Z
Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195
[TBL] [Abstract][Full Text] [Related]
18. SR and SR-related proteins redistribute to segregated fibrillar components of nucleoli in a response to DNA damage.
Sakashita E; Endo H
Nucleus; 2010; 1(4):367-80. PubMed ID: 21327085
[TBL] [Abstract][Full Text] [Related]
19. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
20. Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
Huang Y; Jeong JS; Okamura J; Sook-Kim M; Zhu H; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Jun; 11(12):2367-79. PubMed ID: 22672905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
